Published Notice Of Tribunal Convened Meeting And E-Voting Information
Enclosed copies of the newspaper publication of the notice of Tribunal Convened Meeting and E-Voting information which was published in Business standard (All editions) and Namastey Telangana (Hyderabad edition) on April 28, 2017. Updates on Amalgamation/ Merger / Demerger
The Company is seeking approval of the shareholders for the 'Scheme of Amalgamation and Arrangement between Neuland Laboratories Limited (Transferee Company) and Neuland Health Sciences Private Limited (First Transferor Company) and Neuland Pharma Research Private Limited (Second Transferor Company) and their respective Shareholders and Creditors' ('Scheme')' under Sections 230 to 232 read with Section 66 and other applicable provisions, if any,... Board Meeting On 12-05-2017
Enclosing herewith the copies of newspaper publication on April 22, 2017, of the Notice of the meeting of Board of directors scheduled to be held on Friday, May 12, 2017, inter-alia, to consider and take on record the Audited financial results of the Company for the year ended March 31, 2017. Updates
Attached herewith the copies of Newspaper publication on April 19, 2017 in respect of notice regarding Issue of duplicate share certificate Statement Of Investor Compliants For Quarter Ended 31St March, 2017
Please find attached copy of Statement on Investor Complaints under Regulation 13 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, for the Quarter ended 31st March, 2017 Submission Of Certificate In Compliance With Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Please find attached Certificate in compliance with Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 received from a Practicing Company Secretary for the period from October 1, 2016 to March 31, 2017 Credit Rating
Disclosure pursuant to Regulation 30(4) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed. Neuland Labs gets 2 USFDA observations for Hyderabad facility
The US Food and Drug Administration (USFDA) has made two observations on the manufacturing facility of Neuland Laboratories here. The US regulator had inspected Neuland's Unit 1 at Bonthapally,... Updates
The United States Food and Drug Administration (US FDA) inspected Unit 1, manufacturing facility at Bonthapally, Hyderabad of the Company from 3rd to 7th of April 2017. At the end of the inspection, there were 2 observations given under form 483. The two observations relate to a) procedures followed for the annual quality standards record evaluation and b) cleaning and maintenance of equipment at appropriate intervals during manufacturing campaign....